Pharmas

Purdue Pharma’s $7 Billion Opioid Settlement Gains Momentum as All 50 States Show Support

by

A judge in New York is poised to potentially approve a $7 billion settlement involving Purdue Pharma, following unanimous support from all 50 states. This agreement stems from the pharmaceutical company’s role in the opioid crisis that has claimed countless lives across the nation. Under the settlement, Purdue Pharma will be required to allocate funds toward treatment programs, addressing the impacts of addiction, and enhancing public health initiatives. This financial commitment underscores a significant step in the ongoing efforts to combat the opioid epidemic that has devastated communities and strained healthcare systems. The settlement framework … Read more

Supreme Court Halts Purdue Pharma’s Bankruptcy Plan Amid Rising Multidistrict Litigations: Insights from Law.com’s Aleeza Furman

by

Washington, D.C. – In a significant legal development, the Supreme Court has intervened to halt Purdue Pharma’s bankruptcy plan, a decision that underscores ongoing debates around accountability in the opioid crisis. This move casts uncertainty on the future of the company and its proposed settlements with thousands of plaintiffs. Purdue Pharma, recognized globally for its production of OxyContin, had previously reached a settlement agreement that was integral to its restructuring during bankruptcy proceedings. The deal was meant to temporarily resolve numerous lawsuits tied to the opioid epidemic, offering billions in compensation. However, with the Supreme … Read more

Supreme Court Decision Shakes Up Purdue Pharma’s Bankruptcy Strategy, Impacting Future Mass Tort Litigations

by

Washington, D.C. — The UXPreme Court has recently handed down a decision regarding Purdue Pharma’s bankruptcy strategy that stands to influence future legal strategies of companies embroiled in mass tort litigations. This ruling is a key development, coming amidst a noted uptick in multidistrict litigation cases, which are increasingly constituting a significant portion of the federal civil docket. Purdue Pharma, known for its production of OxyContin, has been at the center of a national controversy surrounding the opioid crisis in the United States. The firm sought bankruptcy protection as a mechanism to settle thousands of … Read more

Supreme Court Strikes Down Purdue Pharma’s Reorganization Plan, Reshapes Chapter 11 Landscape

by

Washington, D.C. — In a landmark decision that reshaped the landscape of Chapter 11 bankruptcy law, the U.S. Supreme of Court delivered a split ruling on Thursday that struck down Purdue Pharma LP’s controversial reorganization plan. The justices ruled that the plan’s provision for nonconsensual third-party releases, which would have shielded parties not directly involved in the bankruptcy from lawsuits, did not align with lawful bankruptcy proceedings. The ruling has stirred a robust debate in the legal community about the implications for future corporate bankruptcies and the rights of individuals harmed by corporate actions, such … Read more